Nisa Investment Advisors’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,518
Closed -$22.3K 3001
2025
Q3
$22.3K Hold
1,518
﹤0.01% 1945
2025
Q2
$14.9K Buy
1,518
+998
+192% +$8.26K ﹤0.01% 2077
2025
Q1
$3.78K Sell
520
-341
-40% -$2.98K ﹤0.01% 2317
2024
Q4
$6.73K Buy
861
+248
+40% +$2.04K ﹤0.01% 2216
2024
Q3
$4.54K Buy
613
+16
+3% +$135 ﹤0.01% 2239
2024
Q2
$4.78K Buy
597
+506
+556% +$4.52K ﹤0.01% 2275
2024
Q1
$1.06K Buy
91
+36
+65% +$399 ﹤0.01% 2359
2023
Q4
$614 Buy
55
+5
+10% +$46 ﹤0.01% 2368
2023
Q3
$772 Sell
50
-1,090
-96% -$18.3K ﹤0.01% 2439
2023
Q2
$21.6K Buy
+1,140
New +$20K ﹤0.01% 2068

Other funds holding ETNB

Nisa Investment Advisors's ETNB Position: Q4 2025 in Review

Nisa Investment Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,518 shares — an estimated $22.3K sold.

Nisa Investment Advisors first reported a position in ETNB in Q2 2023 and held it in 10 quarters. The position peaked at $22.3K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Nisa Investment Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,518 89bio shares in Q4 2025, an estimated $22.3K.
  • Nisa Investment Advisors first reported a position in 89bio in Q2 2023 and held it in 10 quarters.
  • Nisa Investment Advisors's 89bio position peaked at $22.3K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.